all report title image

U.S. NON ONCOLOGY BIOPHARMACEUTICALS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

U.S. Non-oncology Biopharmaceuticals Market, By Product Type (Biologics and Biosimilars), By Drug Class (Monoclonal Antibody, Enzyme Replacement Therapy, Erythropoietin, Interferon, Colony-stimulating Factor, Botulinum Toxin, Fusion Protein, Vaccines, Human Recombinant Insulin, Blood Factors, Human Growth Hormone, and Others), By Disease Indication (Diabetes, Rheumatoid Arthritis, Psoriatic Arthritis, Multiple Sclerosis, Hemophilia, Anemia, Age-related Macular Degeneration, Hepatitis B, Cystic Fibrosis, Osteoporosis, Crohn’s Disease, Ulcerative Colitis, Psoriasis, Ankylosing Spondylitis, and Others (Cardiac Diseases and Others))

Published In: 23 Jan, 2026
Code: CMI2575
Page number: 153
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Ingographics Image

Table of Contents (Version-2026)

Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Product Type
Market Snippet, By Drug Class
Market Snippet, By Disease Indication

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Impact Analysis
Recent Product Approval/Launch
Merger-Acquisition Scenario
Regulatory Scenario
Reimbursement Scenario
Pest Analysis
Market Challenges
Top 10 Non-oncology Biologics Brand Share
Major Biopharmaceuticals Administration Method
Analysis Of Mode Of Administration
Epidemiology
Pest Analysis
Porter’s Five Forces Analysis

U.S. Non-oncology Biopharmaceuticals Market, By Product Type, 2026-2033(USD Bn)

Introduction

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Biologics

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Biosimilars

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

U.S. Non-oncology Biopharmaceuticals Market, By Drug Class, 2026-2033(USD Bn)

Introduction

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Blood Factors

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Botulinum Toxin

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Colony-stimulating Factor

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Enzyme Replacement Therapy

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Erythropoietin

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Fusion Protein

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Human Growth Hormone

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Interferon

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Monoclonal Antibody

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Recombinant Human Insulin

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Vaccines

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Others

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

U.S. Non-oncology Biopharmaceuticals Market, By Disease Indication, 2026-2033 (USD Bn)

Introduction

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Age-related Macular Degeneration

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Anemia

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Ankylosing Spondylitis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Crohn’s Disease

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Cystic Fibrosis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Diabetes

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Hemophilia

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Hepatitis B

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Multiple Sclerosis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Osteoporosis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Psoriasis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Psoriatic Arthritis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Rheumatoid Arthritis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Ulcerative Colitis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Others

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Competitive Landscape

Heat Map Analysis
Company Profiles

Sanofi S.A.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Pfizer, Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Johnson & Johnson

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Novartis International AG

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Amgen, Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Eli Lilly and Company

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

AbbVie Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Bristol - Myers Squibb Company

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

F. Hoffmann-La Roche AG

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Novo Nordisk A/S

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

GlaxoSmithKline plc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

UCB Pharma

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Teva Pharmaceutical Industries Ltd.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Takeda Pharmaceutical Company Ltd

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

AstraZeneca Plc

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Mylan N.V.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

LEO Pharma A/S

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Boehringer Ingelheim GmbH

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Alexion Pharmaceuticals Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Merck & Co., Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Elusys Therapeutics, Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Swedish Orphan Biovitrum AB

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Samsung Bioepis NL B.V.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Biogen Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Theratechnologies Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Section

References
Research Methodology
About us and Sales Contact

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

DUNS Registered

860519526

ESOMAR

Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch

Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.

Download Free Sample of Entire Report (Version 2026)

No credit card required*

I acknowledge that I have read the Privacy Policy

What's Inside the Sample Report?

Current Industry Events of 2026, and Its Impact on the Market
Market Size Estimation – Historical (2020–2024), Current (2026), and Forecast (2026-2033)
Regional Breakdown – North America, Europe, Asia Pacific, Middle East, Africa, Latin America and across 35 countries
Competitive Landscape – Company market share analysis, product benchmarking, and detailed Company Profiles for more than 25+ players.
Customer Intelligence – Customers profiles of more than 50 Customers
Segmental Analysis – Market Size, Y-o-Y growth rate, Trends, and use-cases across more than 5 segments, and 25 sub-segments.
Pricing Analysis – Pricing Dashboard, by geographies and by Companies.
Key Market Drivers, Challenges & Future Trends – Impact analysis on growth
Customized Insights Section tailored to client-specific questions or industry focus.